The U.S. Food and Drug Administration has announced a milestone in its voluntary sodium reduction program by completing the Phase I target and issuing draft guidance for Phase II. In this next phase, the FDA plans to further reduce sodium levels in packaged and processed food by 20%, to bring the average intake to about 2,750 milligrams per day.
According to the U.S. Dietary Guidelines, a person should not consume more than 2,300 milligrams of sodium per day, which is about one teaspoon of salt. The FDA launched its sodium reduction program in 2021, setting a 2.5-year target. The goal for Phase I was to lower the average daily sodium intake from 3,400 milligrams to 3,000 milligrams.
